John T H Mandeville MD PhD
Oculo-Plastic & Orbital Reconstructive Surgery
Past President, Ophthalmic Consultants of Boston
Join to View Full Profile
97 Libbey Industrial ParkwaySuite 100East Weymouth, MA 02189
Phone+1 781-331-3300
Fax+1 781-331-1035
Dr. Mandeville is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Mandeville is an ophthalmologist based in East Weymouth, MA, with subspecialties in oculo-plastic and orbital reconstructive surgery. He completed his ophthalmology residency at UCLA and a fellowship in ophthalmic plastic and reconstructive surgery at Massachusetts Eye and Ear Infirmary. Dr. Mandeville has held notable leadership roles, including past president of Ophthalmic Consultants of Boston. His expertise includes procedures such as blepharoplasty and orbital implants, and he has published extensively on related topics. He has also been involved in clinical trials for thyroid eye disease and is a Fellow of the American Academy of Ophthalmology.
Education & Training
Massachusetts Eye and Ear InfirmaryFellowship, Ophthalmic Plastic and Reconstructive Surgery, 2001 - 2003
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 1998 - 2001
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1997 - 1998
New York Presbyterian Hospital (Columbia Campus)Pathology, 1989 - 1997
Columbia University Vagelos College of Physicians and SurgeonsClass of 1997
Certifications & Licensure
MA State Medical License 2001 - 2026
RI State Medical License 2001 - 2003
CA State Medical License 1997 - 2001
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- An Open-label Study for Non-responders of VRDN-001-101 and VRDN-001-301 (OLE) Start of enrollment: 2023 Feb 01
- A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants with Thyroid Eye Disease (TED) Start of enrollment: 2024 May 23
- An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2) Start of enrollment: 2023 Nov 14
- Join now to see all
Publications & Presentations
PubMed
- Large Cell Acanthoma of the Conjunctiva: Clinicopathologic and Immunohistochemical Features.Frederick A. Jakobiec, Paula Cortes Barrantes, Lina Ma, John T. Mandeville
Ocular Oncology and Pathology. 2019-01-16 - 1 citationsOphthalmic Plastic Surgery in Patients 100 Years and Older.Natalie Wolkow, David A. Weinberg, Thomas A Bersani, Michael K. Yoon, Daniel R. Lefebvre
Ophthalmic Plastic and Reconstructive Surgery. 2019-01-01 - 21 citationsA Case Series and Review of Bisphosphonate-associated Orbital InflammationDaniel R. Lefebvre, John T Mandeville, Yoshihiro Yonekawa, Jorge G. Arroyo, Nurhan Torun
Ocular Immunology and Inflammation. 2014-08-25
Press Mentions
Kalter: Optometrists Eye New DutiesApril 8th, 2017
Professional Memberships
- Councilor
- Member
- Massachusetts Society of Eye Physicians and SurgeonsPast President
- New England Oculoplastics SocietyMember
- New England Ophthalmological SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
